| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2878479 | The Annals of Thoracic Surgery | 2010 | 7 Pages |
Abstract
Aprotinin use during isolated primary CABG reduced blood loss significantly, but was not associated with short-term or long-term mortality and complications. Aprotinin use in relatively low-risk CABG patients was effective and safe in a Chinese (Asian) population.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Xianqiang MD, Zhe MD, Hushan MD, Shiju MD, Yang MD, Hao MD, PhD, Shengshou MD,